Fig. 2
From: Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
Objective partial response in the right-posterior pectoral lymph node conglomerate. (Left) Before treatment with pembrolizumab. (Right) After four cycles of pembrolizumab